Jiangsu Key Lab of New Drug Research and Clinical Pharmacy (Xuzhou Medical College) was established in 2014, which is equipped with sub-laboratories in the areas of molecular biology, behavioral science, clinical pharmacy, chemical synthesis, pharmaceutic preparation, pharmaceutical analysis and others, with the building area of 2, 000 square meters and total value of equipments more than 30 million. 45 full-time research members hold positions in this lab, including 27 professors and associate professors, 36 members with doctoral degree, 1 and 5 awarded to second and third levels of provincial “333 Program”, 1 provincial “Double hit” talent, 3 and 5 admitted to “Qing-Lan Program” for Young Academic Leaders and Young Excellent Talents, 7 endowed with “Six Talent Peaks” project.
Four research directions in this lab are involved in a diverse range of research topics including (1) the pathogenesis of diseases and target discovery; (2) drug screening and druggability research; (3) determination and application of bioactive molecules; and (4) clinical evaluation and reasonable application of drugs, which has combined disease mechanism, target discovery, drug exploitation with clinical evaluation to implement scientific research, talent cultivation and achievement transformation. In the past 5 years, the lab has undertaken more than 100 kinds of scientific research projects, including 27 National Natural Science Foundation projects and 25 lateral commissioned projects. More than 140 high-quality papers have been published on world-famous periodicals, such as Angew Chem Int Edit、Mass Spec Rev、Biosens Bioelectron、Nanoscal、Sci Rep etc, among which, more than 30 publications were higher than 3.0 (IF) and the highest IF was 11.366.